ADURO BIOTECH INC's ticker is ADRO and the CUSIP is 00739L101. A total of 64 filers reported holding ADURO BIOTECH INC in Q3 2020. The put-call ratio across all filers is 0.84 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $29,000 | +2800.0% | 11,831 | +1901.9% | 0.00% | – |
| Q4 2019 | $1,000 | 0.0% | 591 | -24.3% | 0.00% | – |
| Q3 2019 | $1,000 | -50.0% | 781 | -46.4% | 0.00% | – |
| Q2 2019 | $2,000 | -60.0% | 1,456 | +15.9% | 0.00% | – |
| Q1 2019 | $5,000 | +400.0% | 1,256 | +216.4% | 0.00% | – |
| Q4 2018 | $1,000 | -93.8% | 397 | -81.9% | 0.00% | – |
| Q4 2017 | $16,000 | +33.3% | 2,198 | +99.8% | 0.00% | – |
| Q3 2017 | $12,000 | +200.0% | 1,100 | +190.2% | 0.00% | – |
| Q4 2016 | $4,000 | +100.0% | 379 | +111.7% | 0.00% | – |
| Q3 2016 | $2,000 | -98.0% | 179 | -97.9% | 0.00% | -100.0% |
| Q2 2016 | $98,000 | -62.6% | 8,679 | -57.6% | 0.00% | -75.0% |
| Q1 2016 | $262,000 | +70.1% | 20,462 | +275.0% | 0.00% | +100.0% |
| Q4 2015 | $154,000 | +120.0% | 5,456 | +51.6% | 0.00% | +100.0% |
| Q3 2015 | $70,000 | – | 3,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVARD MANAGEMENT CO INC | 640,595 | $4,708,000 | 1.20% |
| BVF INC/IL | 287,776 | $2,115,000 | 0.19% |
| ORACLE INVESTMENT MANAGEMENT INC | 111,542 | $820,000 | 0.18% |
| Sofinnova Investments, Inc. | 189,579 | $1,393,000 | 0.12% |
| CENTAURUS FINANCIAL, INC. | 85 | $624,000 | 0.11% |
| Artal Group S.A. | 550,000 | $4,043,000 | 0.10% |
| Vident Investment Advisory, LLC | 305,311 | $2,244,000 | 0.09% |
| Virtus ETF Advisers LLC | 61,463 | $452,000 | 0.05% |
| Foundry Partners, LLC | 106,907 | $786,000 | 0.03% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 239,301 | $1,759,000 | 0.02% |